Company Filing History:
Years Active: 2007
Title: Han Cheng Zhang - Innovator in Kinase Inhibitors
Introduction
Han Cheng Zhang is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of kinase inhibitors. His work is essential for advancing treatments for various disorders mediated by kinases.
Latest Patents
Han Cheng Zhang holds 1 patent for his invention titled "Substituted pyrrolines as kinase inhibitors." This patent focuses on novel substituted pyrroline compounds that are useful as kinase or dual-kinase inhibitors. The invention also includes methods for producing these compounds and methods for treating or ameliorating disorders related to kinase or dual-kinase activity.
Career Highlights
Han Cheng Zhang is currently employed at Janssen Pharmaceutica NV, where he continues to innovate in the pharmaceutical industry. His work at Janssen has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Bruce E. Maryanoff and David F. McComsey. Their collective expertise enhances the research environment and fosters innovation within the company.
Conclusion
Han Cheng Zhang is a distinguished inventor whose work on kinase inhibitors is paving the way for new therapeutic options. His contributions to the field are invaluable and demonstrate the importance of innovation in medicine.